Large-scale international validation of the ADO index in subjects with COPD: An individual subject data analysis of 10 cohorts

BMJ Open

Volumn 2, Issue 6, 2012, Pages

  Puhan, Milo A ^a,b   Hansel, Nadia N ^c   Sobradillo, Patricia ^d   Enright, Paul ^e   Lange, Peter ^f   Hickson, Demarc ^g,h   Menezes, Ana M ⁱ   Riet, Gerben Ter ^j   Held, Ulrike ^b   Domingo Salvany, Antonia ^k,o   Mosenifar, Zab ^l   Antó, Josep M ^k,m,n,o   Moons, Karel G M ^p   Kessels, Alphons ^q   Garcia Aymerich, Judith ^k,m,n,o  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITY OF ARIZONA   (United States)

^f HVIDOVRE HOSPITAL   (Denmark)

^g JACKSON STATE UNIVERSITY   (United States)

^h UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

ⁱ FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^j UNIVERSITY OF AMSTERDAM   (Netherlands)

^k HOSPITAL DEL MAR   (Spain)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

ⁿ UNIVERSITAT POMPEU FABRA   (Spain)

^o CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADO INDEX; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALIBRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; RESPIRATORY TRACT PARAMETERS; RISK ASSESSMENT; SECONDARY HEALTH CARE; SENSITIVITY ANALYSIS; TERTIARY HEALTH CARE; VALIDATION PROCESS; VALIDATION STUDY;

EID: 84873883218     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002152     Document Type: Article

References (37)

1. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412. (Pubitemid 43180921)
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
3. Guo JJ, Pandey S, Doyle J, et al. A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group. Value Health 2010;13:657-66.
4. Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA 2007;298:1209-12. (Pubitemid 47403108)
5. Politi MC, Han PK, Col NF. Communicating the uncertainty of harms and benefits of medical interventions. Med Decis Making 2007;27:681-95. (Pubitemid 47547605)
6. Moons KG, Royston P, Vergouwe Y, et al. Prognosis and prognostic research: what, why, and how? BMJ 2009;338:b375.
7. Global Strategy for Diagnosis, Management, and Prevention of COPD. 2010. http://wwwgoldcopdcom/GuidelinesResourcesasp?l1=2&l2=0 (accessed 10 Sept 2012).
8. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46. (Pubitemid 38807371)
9. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
10. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2011;34(Suppl 1):S11-61.
11. National Collaborating Centre for Cancer. NICE clinical guideline 58: Prostate cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence. 2008. http://www.nice.org.uk/cg58 (accessed 10 Sept 2012).
12. National Collaborating Centre for Cancer. NICE clinical guideline 80: Early and locally advanced breast cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence. 2009. http://www.nice.org.uk/cg80 (accessed 10 Sept 2012).
13. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:396-404.
14. Puhan MA, Zoller M, ter Riet G. COPD: more than respiratory. Lancet 2008;371:27-8.
15. Jones RC, Donaldson GC, Chavannes NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 2009;180:1189-95.
16. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12. (Pubitemid 38269277)
17. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009;374:704-11.
18. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000;19:453-73. (Pubitemid 30126878)
19. Altman DG, Vergouwe Y, Royston P, et al. Prognosis and prognostic research: validating a prognostic model. BMJ 2009;338:b605.
20. Steyerberg EW, Bleeker SE, Moll HA, et al. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003;56:441-7. (Pubitemid 36694096)
21. Janssen KJ, Moons KG, Kalkman CJ, et al. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol 2008;61:76-86. (Pubitemid 350236700)
22. Sobradillo P, Iriberri M, Gomez B, et al. Validation of bode index as a predictor of mortality in COPD patients. 18th Annual Congress of the European Respiratory Society. Berlin: European Respiratory Society, 2008:P531.
23. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1:263-76.
24. Appleyard M, Hansen A, Schnohr P. The Copenhagen City Heart Study: a book of tables with data from the first examination (1976-78) and a five years follow-up (1981-1983). Scand J Soc Med 1989;170:1-160.
25. Carpenter MA, Crow R, Steffes M, et al. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci 2004;328:131-44. (Pubitemid 39295858)
26. Connett JE, Kusek JW, Bailey WC, et al. Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease. Control Clin Trials 1993;14:3S-19S. (Pubitemid 23102307)
27. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-73. (Pubitemid 36583301)
28. Garcia-Aymerich J, Gomez FP, Anto JM. Phenotypic Characterization and Course of Chronic Obstructive Pulmonary Disease in the PAC-COPD Study: design and methods. Arch Bronconeumol 2009;45:4-11.
29. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366:1875-81. (Pubitemid 41690116)
30. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680-5. (Pubitemid 34971850)
31. Moons KG, Donders RA, Stijnen T, et al. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 2006;59:1092-101. (Pubitemid 44389818)
32. Steyerberg E. Applications of prediction models. In: Steyerberg E (ed.). Clinical prediction models - a practical approach to development, validation, and updating. New York: Springer, 2010. pp. 281-310
33. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004;23:1631-60. (Pubitemid 38660414)
34. Vickers AJ. Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers. Am Stat 2008;62:314-20.
35. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006;26:565-74. (Pubitemid 44728772)
36. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-69.
37. Gail MH. The estimation and use of absolute risk for weighing the risks and benefits of selective estrogen receptor modulators for preventing breast cancer. Ann N Y Acad Sci 2001;949:286-91. (Pubitemid 34059992)